Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SafeStitch Medical was a medical device company that developed minimally invasive surgical tools for treating obesity, gastroesophageal reflux disease (GERD), and other digestive tract conditions. The company's portfolio featured endoscopic and laparoscopic devices, most notably the AMID Stapler used for hernia repair and various gastrointestinal stapling systems. These technologies were designed to facilitate procedures through natural orifices or via small incisions to improve patient outcomes and recovery times. In September 2013, SafeStitch Medical merged with TransEnterix, a robotic surgery company, in a move to combine their surgical platform technologies. The resulting entity eventually rebranded as Asensus Surgical.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SafeStitch.